Novartis takes on dry-eye market with drug in-licensing move
April 7, 2017Medical Communications, Sales and Marketing Lubris, Novartis, dry eye
Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications …
Old antibiotic nears new FDA approval after positive trials
April 7, 2017Medical Communications, Research and Development Pfizer, Zavante, Zolyd, antibiotic
Zavante, a biotech company based in San Diego, has unveiled positive results from a recent Phase II/III trials that could …
Top Ten most popular articles on Pharmafile.com this week
April 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday, and medical device recalls have been the flavour of the week, with both GSK and Mylan having to …
Clinical trial shows yoga negates side-effects of prostate cancer treatment
April 7, 2017Medical Communications prostate cancer, prostate treatment, yoga
Men who are treated for prostate cancer display side-effects of treatment by radiation that can often seriously disrupt their personal …
Epicast: Brain Cancer – Epidemiology Forecast to 2024
April 7, 2017Medical Communications, Research and Development brain cancer, pharmafile
Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of …
Faubel takes over RFID specialist SIL
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Faubel, Nachfolger
The Melsungen printer Faubel & Co. Nachfolger GmbH, which mainly produces booklet labels and custom labels for the pharmaceutical industry, …
J&J ordered to pay $5m over false marketing claims
April 6, 2017Sales and Marketing J&J, JJ, lawsuit
Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …
CRISPR: An up close and personal take on precision medicine
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRISR, Precision Medicine
Traditional approaches to patient therapies are increasingly showing their age inefficacy, but a powerful new gene editing technology is making …
Relay Therapeutics appoints Allergan CSO to CEO position
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Relay
Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …
Takeda completes enrollment for largest-ever study of dengue vaccine
April 6, 2017Research and Development Takeda, clinical trial, dengue
Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …
Care Quality Commission targets website which gave prescriptions in 17 seconds
April 6, 2017Medical Communications, Sales and Marketing Care Quality Commission, prescription
The Care Quality Commission (CQC), England’s health and social care service regulator, has identified four online prescription medicine vendors engaging …
Ketamine found to offer hope as last-resort treatment for depression
April 6, 2017Research and Development Ketamine, University of Oxford
Researchers from the University of Oxford have conducted a six-year study looking into the potential therapeutic effects of ketamine as …
House of Lords slams “short-termism” of NHS in new report
April 6, 2017Medical Communications House of Lords, NHS
A new report from the House of Lords has slammed current and past “short-sighted” governments for failing to provide a …
Pfizer resolves pension dispute at Irish facility
April 5, 2017Manufacturing and Production, Research and Development Ireland, Pfizer, Siptu
Pfizer and trade union Siptu have reached an agreement over a pension dispute at the company’s plant at Ringaskiddy in …
Supercomputer discovers how cell membrane shape causes cancer
April 5, 2017Research and Development Cancer, K-Ras
Researchers from Case Western Reserve University School of Medicine have harnessed the power of a supercomputer to analyse one particular …
Researchers identify key protein in cancer drug resistance
April 5, 2017Research and Development Cancer, university of salford
A University of Salford research team has identified a gene which they believe is one of the leading causes of …
GSK hit by recall of 600,000 inhalers
April 5, 2017Manufacturing and Production, Research and Development FDA, GSK, Ventolin
The FDA has released that GSK would be voluntarily recalling close to 600,000 of its Ventolin asthma inhalers across the …
Joanne Estell joins Shield Therapeutics as CFO
April 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Shield Therapeutics has announced that it has recruited Joanne Estell as its new CFO and board member; she will step …
Common antibiotic shows promise as novel PTSD treatment
April 5, 2017Research and Development PTSD, UCL, antibiotic, doxycycline
Research coming out of University College London (UCL) and the University of Zurich has indicated that common antibiotic doxycycline could …
NICE turns down Shire’s pancreatic cancer treatment
April 4, 2017Manufacturing and Production, Sales and Marketing NICE, Pancreatic cancer, Shire
NICE has announced its intention not to recommend the NHS use of Shire’s Onivyde (pegylated liposomal irinotecan) for the treatment …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
